The Venture Codex Logo

The Venture Codex

Vitable Health

1010 N Hancock St, Philadelphia, Pennsylvania, 19123, United States

Overview

Vitable Health is a Philadelphia, PA-based provider of healthcare plans for hourly and uninsured workers that offers an enhanced primary care membership. Members receive in-home primary care visits and virtual visits from a dedicated team of providers. The membership includes access to over 1,000 free prescriptions, labs, and a mental health program for users and their family. The company is led by Founder & CEO Joseph Kitonga. Vitable plans to use new capital to extend its services to over 40 states and to enhance its primary care and care navigation capabilities. The description reflects the company's core product and its stated expansion and improvement objectives. Vitable Health is a Philadelphia-based startup that launched from Y Combinator and focuses on bringing basic health insurance to underserved and low-income communities. The company provides affordable acute healthcare coverage to underinsured or uninsured populations. It was founded by Joseph Kitonga, a 23-year-old whose parents immigrated to the U.S.; the company was born out of Kitonga’s experience watching employees of his parents’ home healthcare agency struggle to secure basic coverage. Vitable’s positioning emphasizes bridging critical gaps in patient care for people who lack adequate insurance. Financially, the company received a $1.6 million commitment led by SoftBank’s Opportunity Fund and including Y Combinator, DNA Capital, Commerce Ventures, MSA Capital, Coughdrop Capital and angels such as Immad Akhund and Allison Pickens. The SoftBank Opportunity Fund’s investment is the fund’s first public commitment from its $100 million vehicle dedicated to investing in startups founded by entrepreneurs of color.

Total raised
$18M
Funding rounds
2
Latest round
Series A
Latest activity
Jul 2024

Industries

  • Health Care
  • Health Insurance
  • Insurance
  • Primary and Urgent Care
Visit website

Recent funding

  1. Series A

    Jul 2024

    $16M

  2. Equity

    Oct 2020

    $2M

Team